{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:16:30Z","timestamp":1790032590993,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47004-9","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:47:28Z","timestamp":1776422848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hematological parameters as predictive indicators of disease stage in patients with cervical cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Muluken","family":"Walle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewudu","family":"Mulatie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negesse","family":"Cherie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdirizak Mahdi","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje Mengesha","family":"Berta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"5","key":"47004_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144(5), 646\u2013674 (2011).","journal-title":"Cell"},{"issue":"16","key":"47004_CR2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1200\/JCO.2016.71.3024","volume":"35","author":"JN Kochenderfer","year":"2017","unstructured":"Kochenderfer, J. N. et al. Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels. J. Clin. Oncol. 35(16), 1803 (2017).","journal-title":"J. Clin. Oncol."},{"key":"47004_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.coviro.2021.09.012","volume":"51","author":"S Regauer","year":"2021","unstructured":"Regauer, S. & Reich, O. The origin of Human Papillomavirus (HPV)\u2014Induced cervical squamous cancer. Curr. Opin. Virol. 51, 111\u2013118 (2021).","journal-title":"Curr. Opin. Virol."},{"issue":"4","key":"47004_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.5306\/wjco.v5.i4.744","volume":"5","author":"SL McGraw","year":"2014","unstructured":"McGraw, S. L. & Ferrante, J. M. Update on prevention and screening of cervical cancer. World J. Clin. Oncol. 5(4), 744 (2014).","journal-title":"World J. Clin. Oncol."},{"issue":"2","key":"47004_CR5","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn, M. et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob. Health. 8(2), e191\u2013e203 (2020).","journal-title":"Lancet Glob. Health"},{"issue":"6","key":"47004_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 68(6), 394\u2013424 (2018).","journal-title":"Cancer J. Clin."},{"key":"47004_CR7","unstructured":"Chuwa, H. Estimating the Total Cost of Cancer Management: A Descriptive Prospective Cohort Study Among Patients with Cervical Cancer at Ocean Road Cancer Institute (Dar es Salaam, 2014)."},{"key":"47004_CR8","first-page":"405","volume":"7","author":"A Sreedevi","year":"2015","unstructured":"Sreedevi, A., Javed, R. & Dinesh, A. Epidemiology of cervical cancer with special focus on India. Int. J. Women\u2019s Health 7, 405 (2015).","journal-title":"Int. J. Women\u2019s Health"},{"key":"47004_CR9","doi-asserted-by":"crossref","unstructured":"Belachew, S. A., Erku, D. A., Mekuria, A. B. & Gebresillassie, B. M. Pattern of chemotherapy-related adverse effects among adult cancer patients treated at Gondar University Referral Hospital, Ethiopia: A cross-sectional study. Drug Healthc. Patient Saf. 83\u201390 (2016).","DOI":"10.2147\/DHPS.S116924"},{"key":"47004_CR10","first-page":"e1772020","volume":"56","author":"DFB Ara\u00fajo","year":"2020","unstructured":"Ara\u00fajo, D. F. B., Cavalcanti, I. D., Larrazabal-Hadj-Idris, B. R. & Peres, A. L. Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer. J. Bras. Patol. Med. Lab. 56, e1772020 (2020).","journal-title":"J. Bras. Patol. Med. Lab."},{"key":"47004_CR11","doi-asserted-by":"crossref","unstructured":"Kumar, T. et al. Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation. Cancer Manag. Res. 6285\u20136297 (2019).","DOI":"10.2147\/CMAR.S195989"},{"issue":"7","key":"47004_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1634\/theoncologist.2013-0326","volume":"19","author":"EJ Kantelhardt","year":"2014","unstructured":"Kantelhardt, E. J. et al. Cervical cancer in Ethiopia: Survival of 1,059 patients who received oncologic therapy. Oncologist 19(7), 727\u2013734 (2014).","journal-title":"Oncologist"},{"key":"47004_CR13","unstructured":"Wondimneh, B. et al. Comparison of hematological and biochemical profile changes in pre-and post-chemotherapy treatment of cancer patients attended at ayder comprehensive specialized hospital, Mekelle, Northern Ethiopia 2019: A retrospective cohort study. Cancer Manag. Res. 625\u2013632 (2021)."},{"issue":"4","key":"47004_CR14","first-page":"651","volume":"7","author":"C Baruah","year":"2022","unstructured":"Baruah, C., Paul, T., Sarma, B., Deka, K. J. & Patowory, P. P. Hematological toxicity in Carcinoma Cervix patients undergoing concurrent Chemo Radiation Therapy or Radiation Therapy alone in a Tertiary Hospital of North East India: A prospective study. Asian Pac. J. Cancer Care. 7(4), 651\u2013655 (2022).","journal-title":"Asian Pac. J. Cancer Care"},{"issue":"1","key":"47004_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12905-021-01185-9","volume":"21","author":"M Wassie","year":"2021","unstructured":"Wassie, M., Aemro, A. & Fentie, B. Prevalence and associated factors of baseline anemia among cervical cancer patients in Tikur Anbesa Specialized Hospital, Ethiopia. BMC Women\u2019s Health. 21(1), 36 (2021).","journal-title":"BMC Women\u2019s Health"},{"issue":"9","key":"47004_CR16","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1097\/IGC.0b013e31826ea0eb","volume":"22","author":"S Mabuchi","year":"2012","unstructured":"Mabuchi, S. et al. Elevated white blood cell count at the time of recurrence diagnosis is an indicator of short survival in patients with recurrent cervical cancer. Int. J. Gynecol. Cancer. 22(9), 1545\u20131551 (2012).","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"10","key":"47004_CR17","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/jjco\/hyy113","volume":"48","author":"S Yanazume","year":"2018","unstructured":"Yanazume, S. et al. Tumor bleeding requiring intervention and the correlation with anemia in uterine cervical cancer for definitive radiotherapy. Jpn. J. Clin. Oncol. 48(10), 892\u2013899 (2018).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"47004_CR18","unstructured":"Abushofa, F. A., Azab, A. E. & Al Ghawi, H. M. Haematological parameter alterations among cervical cancer patients and the relationship between blood groups and cervical cancer disease. Himal. J. Appl. Med. Sci. Res. ;3(2) (2022)."},{"issue":"8","key":"47004_CR19","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.3390\/diagnostics12081910","volume":"12","author":"C Madeddu","year":"2022","unstructured":"Madeddu, C. et al. Pathogenic and prognostic roles of paraneoplastic leukocytosis in cervical cancer: Can genomic-based targeted therapies have a role? A literature review and an emblematic case report. Diagnostics 12(8), 1910 (2022).","journal-title":"Diagnostics"},{"key":"47004_CR20","doi-asserted-by":"publisher","first-page":"1040163","DOI":"10.3389\/fphar.2022.1040163","volume":"13","author":"Y Wen","year":"2022","unstructured":"Wen, Y. et al. Chronic inflammation, cancer development and immunotherapy. Front. Pharmacol. 13, 1040163 (2022).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"47004_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJ Guthrie","year":"2013","unstructured":"Guthrie, G. J. et al. The systemic inflammation-based neutrophil\u2013lymphocyte ratio: Experience in patients with cancer. Crit. Rev. Oncol. Hematol. 88(1), 218\u2013230 (2013).","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"47004_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3109\/1354750X.2012.656705","volume":"17","author":"H-C Kwon","year":"2012","unstructured":"Kwon, H-C. et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 17(3), 216\u2013222 (2012).","journal-title":"Biomarkers"},{"issue":"7","key":"47004_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone, R. L. et al. Paraneoplastic thrombocytosis in ovarian cancer. N. Engl. J. Med. 366(7), 610\u2013618 (2012).","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"47004_CR24","first-page":"e70407","volume":"8","author":"F Arianmanesh","year":"2025","unstructured":"Arianmanesh, F., Bagheri, S., Karimi, M. A., Izadi, S. & Ahmadi, M. H. The evaluation of diagnostic, prognostic, and predictive role of hematologic inflammatory indices NLR, PLR, and LMR in common solid tumors. Cancer Rep. 8(12), e70407 (2025).","journal-title":"Cancer Rep."},{"issue":"1","key":"47004_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/1471-2407-13-350","volume":"13","author":"S Lee","year":"2013","unstructured":"Lee, S. et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 13(1), 350 (2013).","journal-title":"BMC Cancer"},{"issue":"4","key":"47004_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1620\/tjem.236.297","volume":"236","author":"X Hong","year":"2015","unstructured":"Hong, X. et al. Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J. Exp. Med. 236(4), 297\u2013304 (2015).","journal-title":"Tohoku J. Exp. Med."},{"issue":"4","key":"47004_CR27","first-page":"5937","volume":"8","author":"M Gunaldi","year":"2015","unstructured":"Gunaldi, M. et al. Prognostic impact of platelet\/lymphocyte and neutrophil\/lymphocyte ratios in patients with gastric cancer: A multicenter study. Int. J. Clin. Exp. Med. 8(4), 5937 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"1","key":"47004_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijgo.12749","volume":"145","author":"N Bhatla","year":"2019","unstructured":"Bhatla, N. et al. Revised FIGO staging for carcinoma of the cervix uteri. Int. J. Gynecol. Obstet. 145(1), 129\u2013135 (2019).","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"3","key":"47004_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"Cancer J. Clin."},{"issue":"3","key":"47004_CR30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ijrobp.2009.11.010","volume":"79","author":"BS Rose","year":"2011","unstructured":"Rose, B. S. et al. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 79(3), 800\u2013807 (2011).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"47004_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","volume":"352","author":"G Weiss","year":"2005","unstructured":"Weiss, G. & Goodnough, L. T. Anemia of chronic disease. N. Engl. J. Med. 352(10), 1011\u20131023 (2005).","journal-title":"N. Engl. J. Med."},{"key":"47004_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ejogrb.2020.11.044","volume":"256","author":"PSV de Lima","year":"2021","unstructured":"de Lima, P. S. V., Mantoani, P. T. S., Murta, E. F. C. & Nomelini, R. S. Laboratory parameters as predictors of prognosis in uterine cervical neoplasia. Eur. J. Obstet. Gynecol. Reprod. Biol. 256, 391\u2013396 (2021).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"47004_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12957-019-1676-7","volume":"17","author":"W Cao","year":"2019","unstructured":"Cao, W. et al. Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: A systematic review and meta-analysis. World J. Surg. Oncol. 17(1), 132 (2019).","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"47004_CR34","doi-asserted-by":"publisher","first-page":"863","DOI":"10.31557\/APJCP.2019.20.3.863","volume":"20","author":"IPY Prabawa","year":"2019","unstructured":"Prabawa, I. P. Y. et al. Pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as a predictive value of hematological markers in cervical cancer. Asian Pac. J. Cancer Prev. 20(3), 863 (2019).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"47004_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.suronc.2013.12.001","volume":"23","author":"A Paramanathan","year":"2014","unstructured":"Paramanathan, A., Saxena, A. & Morris, D. L. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg. Oncol. 23(1), 31\u201339 (2014).","journal-title":"Surg. Oncol."},{"issue":"6","key":"47004_CR36","first-page":"598","volume":"22","author":"Z Wang","year":"2025","unstructured":"Wang, Z., Hu, H., Bao, Y., Pang, L. & Yang, C. Neutrophils in cancer: From immune defense to tumor promotion. Cancer Biol. Med. 22(6), 598\u2013617 (2025).","journal-title":"Cancer Biol. Med."},{"key":"47004_CR37","doi-asserted-by":"crossref","unstructured":"Tavares-Murta, B. M. et al. Systemic leukocyte alterations are associated with invasive uterine cervical cancer. Int. J. Gynecol. Cancer 20(7) (2010).","DOI":"10.1111\/IGC.0b013e3181ef8deb"},{"issue":"2","key":"47004_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/01.COC.0000017093.79897.DE","volume":"26","author":"MG Alexandrakis","year":"2003","unstructured":"Alexandrakis, M. G. et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am. J. Clin. Oncol. 26(2), 135\u2013140 (2003).","journal-title":"Am. J. Clin. Oncol."},{"key":"47004_CR39","doi-asserted-by":"crossref","unstructured":"Ardi, V. C., Kupriyanova, T. A., Deryugina, E. I. & Quigley, J. P. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc. Natl. Acad. Sci. 104(51):20262\u201320267 (2007).","DOI":"10.1073\/pnas.0706438104"},{"issue":"2","key":"47004_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura, T., Qian, B-Z. & Pollard, J. W. Immune cell promotion of metastasis. Nat. Rev. Immunol. 15(2), 73\u201386 (2015).","journal-title":"Nat. Rev. Immunol."},{"issue":"27","key":"47004_CR41","doi-asserted-by":"publisher","first-page":"44824","DOI":"10.18632\/oncotarget.14827","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Predictive value of hematological markers of systemic inflammation for managing cervical cancer. Oncotarget 8(27), 44824 (2017).","journal-title":"Oncotarget"},{"issue":"1","key":"47004_CR42","first-page":"71","volume":"6","author":"JO Alegbeleye","year":"2023","unstructured":"Alegbeleye, J. O. & Jaja, M. A. Predictive value of pretreatment haematological markers in cervical cancer at a third level health institution. Int. J. Res. Rep. Gynecol. 6(1), 71\u201378 (2023).","journal-title":"Int. J. Res. Rep. Gynecol."},{"issue":"3","key":"47004_CR43","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.21037\/tcr-23-1501","volume":"13","author":"L Jin","year":"2024","unstructured":"Jin, L., Cao, F., Zhang, Y., Dang, Y. & Wang, F. Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer. Transl. Cancer Res. 13(3), 1323\u20131335 (2024).","journal-title":"Transl. Cancer Res."},{"issue":"5","key":"47004_CR44","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3892\/mco.2015.595","volume":"3","author":"K Nakamura","year":"2015","unstructured":"Nakamura, K. et al. Pretreatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapy. Mol. Clin. Oncol. 3(5), 1001\u20131006 (2015).","journal-title":"Mol. Clin. Oncol."},{"key":"47004_CR45","doi-asserted-by":"crossref","unstructured":"Valle-Mendiola, A., Guti\u00e9rrez-Hoya, A., Lagunas-Cruz MdC, Weiss-Steider, B. & Soto-Cruz, I. Pleiotropic effects of IL-2 on cancer: Its role in cervical cancer. Mediat. Inflamm. 2016 (2016).","DOI":"10.1155\/2016\/2849523"},{"issue":"2","key":"47004_CR46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10555-017-9673-1","volume":"36","author":"MZ Wojtukiewicz","year":"2017","unstructured":"Wojtukiewicz, M. Z., Sierko, E., Hempel, D., Tucker, S. C. & Honn, K. V. Platelets and cancer angiogenesis nexus. Cancer Metastasis Rev. 36(2), 249\u2013262 (2017).","journal-title":"Cancer Metastasis Rev."},{"key":"47004_CR47","doi-asserted-by":"crossref","unstructured":"Chen, L., Zhang, F., Sheng, X., Zhang, S. & Chen, Y. Liu B-w. Peripheral platelet\/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte. Medicine 95(32) (2016).","DOI":"10.1097\/MD.0000000000004381"},{"key":"47004_CR48","doi-asserted-by":"crossref","unstructured":"Jonska-Gmyrek, J. et al. Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients. Cancer Manag. Res. 6029\u20136038 (2018).","DOI":"10.2147\/CMAR.S178745"},{"key":"47004_CR49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cca.2018.05.025","volume":"483","author":"M Zhu","year":"2018","unstructured":"Zhu, M. et al. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical cancer. Clin. Chim. Acta. 483, 296\u2013302 (2018).","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"47004_CR50","doi-asserted-by":"publisher","first-page":"16755","DOI":"10.18632\/oncotarget.15157","volume":"8","author":"Q-T Huang","year":"2017","unstructured":"Huang, Q-T. et al. Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies. Oncotarget 8(10), 16755 (2017).","journal-title":"Oncotarget"},{"issue":"1","key":"47004_CR51","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ygyno.2020.10.011","volume":"160","author":"X Han","year":"2021","unstructured":"Han, X. et al. Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies. Gynecol. Oncol. 160(1), 351\u2013360 (2021).","journal-title":"Gynecol. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47004-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:04:34Z","timestamp":1781262274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47004-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47004"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47004-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving humans was approved by the School of Biomedical and Laboratory Sciences Ethical Review Committee (Ref. No.\/SBLS\/97\/2023), UGCSH. Participants were provided with detailed information regarding the study\u2019s objectives and procedures; subsequently, written informed consent was obtained from each participant before data collection. The study was conducted in accordance with the local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18197"}}